Corporate Dems’ Rapidly Growing ‘Dark Money’ Arm
Tax documents reveal the group Center Forward received a record $18.8 million in 2021 and spent big to back conservative Democrats who bucked their party on drug pricing reforms.
H.R. 3
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money
On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.